RZLT
Closed
Rezolute Inc
4.42
-0.04 (-0.90%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.46
Day's Range: 4.145 - 4.48
Send
sign up or login to leave a comment!
When Written:
2.01
Rezolute Inc is a biopharmaceutical company that focuses on developing therapies for rare and metabolic diseases. The company's lead product candidate, RZ358, is a potential treatment for congenital hyperinsulinism (CHI), a rare genetic disorder that causes severe hypoglycemia (low blood sugar) in infants and children. Rezolute is also developing RZ402, a potential treatment for diabetes-related complications such as diabetic macular edema and diabetic nephropathy.
The company was founded in 2010 and is headquartered in Redwood City, California. Rezolute has partnerships with major pharmaceutical companies, including Pfizer and Eli Lilly, to develop and commercialize its products. The company is publicly traded on the NASDAQ under the ticker symbol RZLT.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company was founded in 2010 and is headquartered in Redwood City, California. Rezolute has partnerships with major pharmaceutical companies, including Pfizer and Eli Lilly, to develop and commercialize its products. The company is publicly traded on the NASDAQ under the ticker symbol RZLT.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








